Skip to main content
Novartis
language-selector-globe
Choose Location
language-selector-globeCzech Republic |
CzechEnglish
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
language-selector-globeCzech Republic
CzechEnglish
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • Novartis Česká republika 
      • Novartis v České republice 
      • Strategie 
      • Diverzita a inkluze 
      • Lidé a kultura 
      • Produkty celosvětově 
      • Vedení společnosti v ČR 
      • Naše poslání a vize 
      • Divize Inovativní medicína 
      • Kontakt 
      Budova společnosti Novartis v ČR
      Novartis Česká republika
    • Pacienti a jejich ošetřující 
      • Zodpovědnost vůči pacientům 
      • Pacientské portály v České republice 
      • Produkty celosvětově 
      • Hlášení nežádoucích účinků 
      • Poskytování darů a grantů 
      Babička s vnučkou v objetí
      Pacienti a jejich ošetřující
    • Odborníci ve zdravotnictví 
      • Materiály pro lékaře 
      • Produkty celosvětově 
      • Projekty 
      • Hlášení nežádoucích účinků 
      • Klinické studie 
        • Klinické studie v České republice 
      • VPOIS 
      • Odborné informace 
      Vědec se dívá do mikroskopu
      Odborníci ve zdravotnictví
    • Výzkum a vývoj 
      • Věda a výzkum 
      Vědkyně v laboratoři
      Výzkum a vývoj
    • Životní prostředí, sociální a správní aspekty 
      • Etika, rizika a dodržování předpisů 
      • Přístup 
      • Udržitelnost životního prostředí 
      • Globální zdraví 
      • Etické chování 
      • Whistleblow line CZ 
      Životní prostředí, sociální a správní aspekty
      Životní prostředí, sociální a správní aspekty
    • Novinky 
      • Archiv novinek 
      • Příběhy 
      • Knihovna médií 
      • Kontakt pro média 
      Novinky
      Novinky
    • Kariéra 
      • Nové pracovní příležitosti 
      • Seznamte se s týmy 
      • Osobní růst 
      • Pro absolventy 
      • Jak pracujeme 
      • Leadership Trainee Program v ČR 
      • Benefity 
      • Diverzita a inkluze 
      • Naše ocenění 
      Usmívající se žena v posluchárně
      Kariéra
    • Coronavirus 
      Částice viru SARS CoV 2 na snímku z elektronového mikroskopu.
      Coronavirus
    Vědkyně v laboratoři
    Domů
  1. Home
  2. Nové pracovní příležitosti
  3. Nové pracovní příležitosti
  • Sort by Sort ascending
  • Pracovní pozice Seřadit vzestupně
  • Pobočka
  • Místo
  • Vybrat divizi
  • Byznys
  • Functional Area
  • Datum zveřejnění
Pracovní pozice Seřadit vzestupně Pobočka Místo Vybrat divizi Byznys Functional Area Datum zveřejnění
Central Monitor Hyderabad (Office) India Development Development Research & Development úno 03, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Medical Safety Processes and Projects Manager Hyderabad (Office) India Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Lead Central Monitor Hyderabad (Office) India Development Development Research & Development úno 02, 2026
Scientist in Drug Product Development, Senior Expert Science & Technology(m/f/d) Schaftenau Austria Development Development Research & Development úno 02, 2026
Analytical Expert (Postgraduate Early Talent Program) Basel (City) Switzerland Development Development Others úno 02, 2026
Senior Program Head East Hanover USA Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Clinical Development Medical Manager Shanghai (Shanghai) China Development Development Research & Development úno 02, 2026
Senior Principal Statistical Programmer Basel (City) Switzerland Development Development Research & Development led 30, 2026
Study & Site Operations- US Country Head (Remote) Remote Position (USA) USA Development Development Research & Development led 30, 2026
Principal Statistical Programmer London (The Westworks) United Kingdom Development Development Research & Development led 30, 2026
Medical Director (Neuroscience) London (The Westworks) United Kingdom Development Development Research & Development led 29, 2026
Senior Scientific Engagement Manager Dublin (NOCC) Ireland Development Development Research & Development led 28, 2026
SSO Study Start-Up Manager Midrand South Africa Development Research Research & Development led 28, 2026
Clinical Development Director (Neuroscience) Basel (City) Switzerland Development Development Research & Development led 28, 2026
Vendor Alliance Lead Dublin (NOCC) Ireland Development Development Research & Development led 28, 2026
Clinical Quality Assurance - Program Lead (Associate Director) London (The Westworks) United Kingdom Development Quality Quality led 28, 2026
Global Clinical Operations - SSO Hong Kong Manager Hong Kong Hong Kong Special Administrative Region, China Development Development Research & Development led 26, 2026
Expert Science & Technology - II Changshu (Jiangsu Province) China Development Development Research & Development led 26, 2026
Head Portfolio Strategy & Operations Neuroscience & Gene Therapy Cambridge (Massachusetts) USA Development Development Research & Development led 26, 2026
Clinical Development Medical Director - Cardiology London (The Westworks) United Kingdom Development Development Research & Development led 23, 2026
Warehouse & Logistics Senior Expert - *Legge 68/99 Ivrea Italy Development Development Research & Development led 22, 2026
Global Program Safety Lead Basel (City) Switzerland Development Development Research & Development led 21, 2026
Senior Expert Science & Technology (Analytical Chemistry Oligonucleotides) Basel (City) Switzerland Development Development Research & Development led 21, 2026
PostGraduate Scientist in Downstream Process Development Basel (City) Switzerland Development Development Others led 21, 2026
Manager Evidence Generation Hyderabad (Office) India Development Development Research & Development led 21, 2026
Global Program Safety Lead Basel (City) Switzerland Development Development Research & Development led 21, 2026
Medical Affairs Director, Autoimmune Diseases Barcelona Gran Vía Spain Development Marketing Research & Development led 21, 2026
Global Program Safety Team Lead Basel (City) Switzerland Development Development Research & Development led 20, 2026
Senior Global Program Safety Team Lead Hyderabad (Office) India Development Development Research & Development led 20, 2026
Head Technology Integration & Standards Hyderabad (Office) India Development Development Research & Development led 19, 2026
Director Evidence Generation Dublin (NOCC) Ireland Development Development Research & Development led 19, 2026
Expert Science & Technology Hyderabad (Office) India Development Development Research & Development led 19, 2026
Senior Statistical Programmer Toranomon (NPKK Head Office) Japan Development Development Research & Development led 19, 2026
Expert Science & Technology - (Oligonucleotides/Peptide Therapeutics) Hyderabad (Office) India Development Development Research & Development led 19, 2026
Senior Statistical Programmer Toranomon (NPKK Head Office) Japan Development Development Research & Development led 19, 2026
QP / Senior Quality Manager Radiopharmaceuticals Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Development Quality Quality led 15, 2026
Assoc Director, Statistical Programming London (The Westworks) United Kingdom Development Development Research & Development led 15, 2026
Patient Safety Specialist- Gulf Cluster Dubai Utd.Arab Emir. Development Development Research & Development led 14, 2026
Portfolio Program Management Office Associate Director Barcelona Gran Vía Spain Development Development Research & Development led 14, 2026
Associate Scientist Technical Development - Legge 68/99 (tempo determinato) Ivrea Italy Development Development Research & Development led 13, 2026

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • › Next page
No matching countries found
Hledat

Novartis Česká republika

Navigace Novartis
  • Pacienti a ošetřující osoby
  • Zdravotníci
  • Životní prostředí a sociální aspekty
  • Novinky
  • Kariéra
  • Hlášení nežádoucích událostí
Centrum pro média
  • Archiv novinek
  • Příběhy
Naše portofolio
  • Novartis pipeline
  • Novartis produkty
Další webové stránky Novartis
  • Globální stránka
Footer Bottom
© 2026 Novartis s.r.o
  • Zásady ochrany osobních údajů
  • Podmínky použití
  • Nastavení souborů cookie
  • Mapa stránek
  • Přístupnost webu
Adresář webu Novartis
Tato stránka je určena pro Českou republiku